FITY OTC
Fifty 1 Labs, Inc.
1W: +100.0%
1M: -33.3%
3M: -71.4%
YTD: -66.7%
1Y: -92.9%
3Y: -99.7%
5Y: -100.0%
$0.00
-0.00 (-20.00%)
Weekly Expected Move ±66.6%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0001-0.0128
Volume100,001
Avg Volume15,670,423
Beta2.66
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoel Gagnier
Employees2
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2005-07-18
Websitefifty1labs.com
751 North Drive
Melbourne, FL 32934
US
Melbourne, FL 32934
US
702 576 9864
About Fifty 1 Labs, Inc.
Fifty 1 Labs, Inc. is a Nevada-based holding company that has shifted its focus to biotechnology and telehealth, centering on peptide science for musculoskeletal health, recovery, and performance. The company utilizes AI-driven research and aims to develop a telehealth platform for personalized peptide therapies. Formerly involved in automotive finance, the company is now pursuing growth in the functional medicine and life sciences sectors.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| SEVERSON MARK A | 0 | — | 2007-12-31 | |
| SEVERSON MARK A | 0 | — | 2007-12-31 | |
| SEVERSON MARK A | 0 | — | 2007-10-01 | |
| SEVERSON MARK A | J-Other | 312 | $12.40 | 2007-03-31 |
| SEVERSON MARK A | I-Discretionary | 997 | $12.48 | 2007-03-20 |